| 1. |  1ST Biotherapeutics, Inc. Yongin, South Korea | Biotech | Phase 1 | VIEW |
| 2. |  3PBIOVIAN Turku, Finland (Biovian) / Pamplona, Spain (3P) - now pan-European | CDMO | CDMO - supports clients' pipelines from Discovery through Commercial | VIEW |
| 3. |  3PBIOVIAN Noáin (Navarra), Spain | CDMO | Commercial | VIEW |
| 4. |  5QBD-Biotech Aydat, France | CRO | Service Provider | VIEW |
| 5. |  ADVI Health Washington, DC, USA | CRO | Private Equity Backed | VIEW |
| 6. |  | CRO | - | VIEW |
| 7. |  | CRO | - | VIEW |
| 8. |  Aardvark Therapeutics San Diego, USA | Biotech | Phase 3 | VIEW |
| 9. |  Abcuro, Inc. Newton, Massachusetts, USA | Biotech | Phase 2/3 | VIEW |
| 10. |  Abeona Therapeutics Inc. Cleveland, Ohio, USA | Biotech | Commercial | VIEW |
| 11. |  Abiogen Pharma S.p.A. Pisa, Italy | Biotech | Commercial | VIEW |
| 12. |  Acadia Pharmaceuticals Inc. San Diego, USA | Biotech | Commercial | VIEW |
| 13. |  Access Elevate Hellerup, Denmark | CRO | - | VIEW |
| 14. |  Actaros London, United Kingdom | CRO | Commercial | VIEW |
| 15. |  Acuitas360 Princeton, New Jersey, USA | CRO | - | VIEW |
| 16. |  Adelphi Targis Barcelona, Spain | CRO | - | VIEW |
| 17. |  Advanced Clinical Deerfield, Illinois, USA | CRO | Commercial | VIEW |
| 18. |  Advanz Pharma London, United Kingdom | Biotech | Commercial|Phase 2|Phase 3 | VIEW |
| 19. |  Agios Pharmaceuticals Cambridge, USA | Biotech | Commercial | VIEW |
| 20. |  Agomab Therapeutics Antwerp, Belgium | Biotech | Phase 2 | VIEW |
| 21. |  Agostino Gemelli University Hospital Rome, Italy | CRO | Phase 1-4 | VIEW |
| 22. |  Aico Worldwide Boston, USA | Digital Health | Commercial | VIEW |
| 23. |  Aixial Group Boulogne-Billancourt, France | CRO | - | VIEW |
| 24. |  Ajou University Suwon, South Korea | Biotech | Phase 3 | VIEW |
| 25. |  Akebia Therapeutics Cambridge, USA | Biotech | Commercial | VIEW |
| 26. |  Akkodis Zurich, Switzerland | CRO | Commercial | VIEW |
| 27. |  | CRO | - | VIEW |
| 28. |  | CDMO | Commercial | VIEW |
| 29. |  Aleon Pharma International, Inc. Parsippany, New Jersey, USA | CRO | N/A | VIEW |
| 30. |  Alkeus Pharmaceuticals Cambridge, USA | Biotech | Phase 3 | VIEW |
| 31. |  Allucent Cary, North Carolina, USA | CRO | Commercial | VIEW |
| 32. |  Almac Group Craigavon, United Kingdom | CDMO | Discovery | VIEW |
| 33. |  Altasciences Laval, Quebec, Canada | CRO | Preclinical to Phase II (early-phase development) | VIEW |
| 34. |  Amgen Thousand Oaks, California, United States | Pharma | Discovery through Commercial | VIEW |
| 35. |  Amicus Therapeutics Princeton, New Jersey, USA | Biotech | Commercial | VIEW |
| 36. |  Amplity Health Langhorne, PA, USA | CRO | - | VIEW |
| 37. |  Amylyx Pharmaceuticals Cambridge, USA | Biotech | Phase 3 | VIEW |
| 38. |  Aparito Wrexham, United Kingdom | Digital Health | Commercial | VIEW |
| 39. |  Apellis Pharmaceuticals, Inc. Waltham, Massachusetts, USA | Biotech | Commercial | VIEW |
| 40. |  AplusA Research Lyon, France | CRO | - | VIEW |
| 41. |  Apothecon Pharmaceuticals Pvt. Ltd. Vadodara, India | CDMO | Commercial | VIEW |
| 42. |  Arcera Life Sciences Abu Dhabi, United Arab Emirates | Biotech | Commercial | VIEW |
| 43. |  | CDMO | Commercial | VIEW |
| 44. |  Argo Biopharma Shanghai, China | Biotech | Phase 2 | VIEW |
| 45. |  Aristotle University of Thessaloniki - School of Pharmacy Thessaloniki, Greece | Biotech | Discovery | VIEW |
| 46. |  | CRO | Commercial | VIEW |
| 47. |  | Digital Health | - | VIEW |
| 48. |  Assistance Publique - Hôpitaux de Marseille (AP-HM) Marseille, France | Biotech | Clinical | VIEW |
| 49. |  Assistance Publique - Hôpitaux de Paris (AP-HP) Paris, France | Digital Health | Commercial | VIEW |
| 50. |  Astellas Pharma Inc. Tokyo, Japan | Pharma | Discovery to Phase 3 | VIEW |
| 51. |  AstraZeneca Cambridge, United Kingdom | Pharma | Phase 1|Phase 2|Phase 3|Pre-registration|Commercial | VIEW |
| 52. |  AutoCruitment Atlanta, Georgia, USA | CRO | Commercial | VIEW |
| 53. |  Autolus Therapeutics London, United Kingdom | Biotech | Commercial + Phase 1/2 | VIEW |
| 54. |  BC Platforms Zurich, Switzerland | Digital Health | Commercial | VIEW |
| 55. |  | Biotech | Commercial | VIEW |
| 56. |  BIAL São Mamede do Coronado, Trofa, Porto, Portugal | Biotech | Phase 2 (lead candidate) | VIEW |
| 57. |  | Biotech | Discovery | VIEW |
| 58. |  BRIM Biotechnology, Inc. Taipei, Taiwan | Biotech | Phase 3 | VIEW |
| 59. |  Bachem Holding AG Bubendorf, Switzerland | CDMO | Commercial | VIEW |
| 60. |  | Biotech | Commercial | VIEW |
| 61. |  | Pharma | Discovery through Commercial | VIEW |
| 62. |  Baylor Scott & White Health Dallas, Texas, USA | MedTech | Commercial | VIEW |
| 63. |  Beacon Scientific Consulting Ltd Cambridge, United Kingdom | CRO | - | VIEW |
| 64. |  Belief BioMed Shanghai, China | Biotech | Commercial | VIEW |
| 65. |  Beren Therapeutics P.B.C. Thousand Oaks, USA | Biotech | Phase 3 | VIEW |
| 66. |  Berg Health Framingham, Massachusetts, USA | Biotech | Phase 1/2 | VIEW |
| 67. |  Beyond Drug Development Brisbane, Australia | CRO | Discovery | VIEW |
| 68. |  BioAgilytix Labs Durham, NC, USA | CRO | Private Equity-Backed | VIEW |
| 69. |  BioData Solutions Lawrence, Kansas, USA | Biotech | - | VIEW |
| 70. |  BioLineRx Ltd. Modiin, Israel | Biotech | Commercial | VIEW |
| 71. |  BioMed Valley Discoveries Kansas City, Missouri, USA | Biotech | Clinical (Phase 1-2) | VIEW |
| 72. |  BioNTech SE Mainz, Germany | Biotech | Commercial | VIEW |
| 73. |  BioPharma Services Inc. Toronto, Canada | CRO | Commercial | VIEW |
| 74. |  BioScience Communications New York, NY, USA | CRO | - | VIEW |
| 75. |  Bioclinica Princeton, New Jersey, USA | CRO | Commercial | VIEW |
| 76. |  Biocodex Mexico Mexico City, Mexico | Biotech | Commercial | VIEW |
| 77. |  | Biotech | Commercial | VIEW |
| 78. |  Biotech Advisory Lab Basel, Switzerland | CRO | Commercial | VIEW |
| 79. |  BirchBioMed Inc. Vancouver, Canada | Biotech | Phase 2/3 | VIEW |
| 80. |  Blueprint Medicines Cambridge, USA | Biotech | Commercial | VIEW |
| 81. |  Bluphytal S.r.l. Parma, Italy | CRO | - | VIEW |
| 82. |  Boehringer Ingelheim Ingelheim am Rhein, Germany (near Mainz and Frankfurt) | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 83. |  Boston Institute of Biotechnology Southborough, USA | CDMO | Commercial | VIEW |
| 84. |  BrainXell, Inc. Madison, WI, USA | Biotech | Preclinical | VIEW |
| 85. |  Bristol Myers Squibb Princeton, New Jersey, United States | Pharma | Phase 1-3 and Commercial | VIEW |
| 86. |  Burjeel Holdings Abu Dhabi, United Arab Emirates | Digital Health | Commercial | VIEW |
| 87. |  CAMP4 Therapeutics Cambridge, USA | Biotech | Phase 1 | VIEW |
| 88. |  CCHO (Center of Clinical, Health Economics and Outcomes Research) Dubai, United Arab Emirates | CRO | - | VIEW |
| 89. |  CCS Associates, Inc. San Jose, California, USA | CRO | - | VIEW |
| 90. |  CEMKA Bourg-la-Reine, France | CRO | Commercial | VIEW |
| 91. |  CEVA Logistics Marseille, France | CRO | Commercial | VIEW |
| 92. |  CMC Pharmaceuticals Solon, Ohio, USA | CDMO | Commercial | VIEW |
| 93. |  CS Pharmaceuticals Limited London, United Kingdom | Biotech | Phase 2 | VIEW |
| 94. |  | Digital Health | Commercial | VIEW |
| 95. |  CURE5 Foundation New York, USA | Biotech | Discovery | VIEW |
| 96. |  Cactus Life Sciences Princeton, USA | CRO | - | VIEW |
| 97. |  | CRO | N/A | VIEW |
| 98. |  Calliditas Therapeutics Stockholm, Sweden | Biotech | Commercial | VIEW |
| 99. |  | Biotech | Commercial | VIEW |
| 100. |  Carbogen Amcis Bubendorf, Switzerland | CDMO | Commercial | VIEW |
| 101. |  Cardinal Health Dublin, Ohio, USA | MedTech | Commercial | VIEW |
| 102. |  Care Access Boston, Massachusetts | CRO | Commercial | VIEW |
| 103. |  Carelon Research Wilmington, Delaware, USA | CRO | Commercial | VIEW |
| 104. |  Carol Davila University of Medicine and Pharmacy Bucharest, Romania | Biotech | Discovery | VIEW |
| 105. |  Carroll Bio-Consulting Boston, USA | Biotech | Commercial | VIEW |
| 106. |  Catalent, Inc. Tampa, Florida, USA | CDMO | Commercial | VIEW |
| 107. |  Catalyst Pharmaceuticals, Inc. Coral Gables, USA | Biotech | Commercial | VIEW |
| 108. |  Cellares South San Francisco, USA | CDMO | Commercial | VIEW |
| 109. |  | Biotech | Phase 2 | VIEW |
| 110. |  Cellipont Bioservices The Woodlands, Texas, USA | CDMO | Commercial | VIEW |
| 111. |  Cencora Conshohocken, Pennsylvania, USA | Pharma | Commercial | VIEW |
| 112. |  Cencora Conshohocken, Pennsylvania, United States | Pharma | Commercial (as distributor/logistics provider) | VIEW |
| 113. |  Center for Neuromusculoskeletal Restorative Medicine Limited Shatin, Hong Kong | Biotech | Preclinical | VIEW |
| 114. |  Centogene Rostock, Germany | Diagnostics | Preclinical | VIEW |
| 115. |  Centre Hospitalier Universitaire (CHU) de Toulouse Toulouse, France | MedTech | Discovery | VIEW |
| 116. |  Cepton Strategies Paris, France | CRO | - | VIEW |
| 117. |  Cerbios-Pharma SA Barbengo-Lugano, Switzerland | CDMO | Preclinical|Clinical|Commercial | VIEW |
| 118. |  Certara Princeton, New Jersey, USA | CRO | N/A | VIEW |
| 119. |  Chan Zuckerberg Biohub Network San Francisco, USA | Biotech | Discovery | VIEW |
| 120. |  Charles River Laboratories Wilmington, Massachusetts, USA | CRO | Commercial | VIEW |
| 121. |  Charles River Laboratories Wilmington, Massachusetts, USA | CRO | Commercial | VIEW |
| 122. |  Chiba University Chiba, Japan | Biotech | Phase 2 | VIEW |
| 123. |  Children's Clinical University Hospital (BKUS) Riga, Latvia | Digital Health | - | VIEW |
| 124. |  China Resources Double-Crane Pharmaceutical Co., Ltd. Beijing, China | Pharma | Commercial | VIEW |
| 125. |  Chong Kun Dang Pharmaceutical Corp. Seoul, South Korea | Pharma | Commercial | VIEW |
| 126. |  Chugai Pharma Taiwan Ltd. Taipei, Taiwan | Pharma | Commercial | VIEW |
| 127. |  Chugai Pharmaceutical Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 128. |  Cincinnati Children's Hospital Medical Center Cincinnati, USA | Biotech | Commercial | VIEW |
| 129. |  City of Hope Duarte, California, USA | Biotech | Commercial | VIEW |
| 130. |  Claire Davies Pharma Consulting Limited Deal, United Kingdom | CRO | Commercial | VIEW |
| 131. |  ClearView Healthcare Partners Newton, USA | CRO | - | VIEW |
| 132. |  Cleveland Clinic Foundation Cleveland, Ohio, USA | Biotech | Discovery | VIEW |
| 133. |  ClinChoice Fort Washington, USA / Shanghai, China | CRO | N/A | VIEW |
| 134. |  Clinical Outcomes Solutions Chicago, USA / Folkestone, UK | CRO | - | VIEW |
| 135. |  Clinical Process Services (CPS) Dubai, United Arab Emirates | CRO | Commercial | VIEW |
| 136. |  Clinical Service Center (CSC) Suzhou, China | CRO | Commercial | VIEW |
| 137. |  Clinical2Digital San Diego, USA | Digital Health | Commercial | VIEW |
| 138. |  Clinuvel Pharmaceuticals Melbourne, Australia | Biotech | Commercial | VIEW |
| 139. |  Coave Therapeutics Paris, France | Biotech | Preclinical | VIEW |
| 140. |  Codexis, Inc. Redwood City, California, USA | Biotech | Commercial | VIEW |
| 141. |  Cold Chain Technologies Franklin, Massachusetts, USA | MedTech | Commercial | VIEW |
| 142. |  Conexus Solutions, Inc. Branchburg, USA | Digital Health | Commercial | VIEW |
| 143. |  Consonance Capital New York, USA | Biotech | Discovery | VIEW |
| 144. |  Coral Healthcare Beijing, China | Digital Health | Commercial | VIEW |
| 145. |  Covance Princeton, New Jersey, USA | CRO | N/A - Service provider, not drug developer | VIEW |
| 146. |  Cupperson London, United Kingdom | CRO | Self-funded | VIEW |
| 147. |  Curatis Liestal, Switzerland | Biotech | Phase 3 | VIEW |
| 148. |  | Biotech | Phase 2 | VIEW |
| 149. |  Curebase San Francisco, USA | Digital Health | Commercial | VIEW |
| 150. |  Curestack Tampa, Florida, USA | Digital Health | Commercial | VIEW |
| 151. |  Cuttsy+Cuttsy Cambridge, United Kingdom | CRO | N/A (Service Provider) | VIEW |
| 152. |  Cyborg Advisor New York, USA | Digital Health | Commercial | VIEW |
| 153. |  Cytel Cambridge, Massachusetts, USA | CRO | N/A - Service Provider | VIEW |
| 154. |  | CRO | Service Provider | VIEW |
| 155. |  Cytiva Marlborough, Massachusetts, USA | MedTech | Commercial | VIEW |
| 156. |  Cytochroma Edinburgh, United Kingdom | Biotech | Discovery | VIEW |
| 157. |  Cytocom, Inc. Fort Collins, Colorado, USA | Biotech | Phase 2/Phase 3 | VIEW |
| 158. |  Cytonus Therapeutics Carlsbad, California, United States | Biotech | Phase 1 | VIEW |
| 159. |  Cytovance Biologics Oklahoma City, USA | CDMO | Commercial | VIEW |
| 160. |  | Biotech | Phase I/II - Phase II | VIEW |
| 161. |  DP Clinical, Inc. Rockville, Maryland, USA | CRO | - | VIEW |
| 162. |  Daicel Chiral Technologies Hyderabad, India (Regional HQ); West Chester, PA, USA (Global HQ) | CDMO | Commercial | VIEW |
| 163. |  Daiichi Sankyo Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 164. |  Daiichi Sankyo Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 165. |  Dankook University Yongin and Cheonan, South Korea | Biotech | Phase 2 | VIEW |
| 166. |  Dartmouth College Hanover, USA | Biotech | Phase 3 | VIEW |
| 167. |  Day One Biopharmaceuticals Brisbane, United States | Biotech | Commercial | VIEW |
| 168. |  Debiopharm Lausanne, Switzerland | Biotech | Phase 1, Phase 2, Phase 3 | VIEW |
| 169. |  Definitive Healthcare Framingham, USA | Digital Health | Commercial | VIEW |
| 170. |  Deloitte France Puteaux (Paris La Défense), France | CRO | Commercial | VIEW |
| 171. |  Delve-RW LLC Franklin, Massachusetts, USA | CRO | Commercial | VIEW |
| 172. |  Disc Medicine, Inc. Watertown, Massachusetts, USA | Biotech | Phase 3 | VIEW |
| 173. |  Dompé Farmaceutici Milan, Italy | Biotech | Commercial | VIEW |
| 174. |  Drug & Biotechnology Development, LLC Clearwater, USA | CRO | Commercial | VIEW |
| 175. |  | CRO | Commercial | VIEW |
| 176. |  ELIQUENT Life Sciences Washington, DC, USA | CRO | Commercial | VIEW |
| 177. |  ENCell Co., Ltd. Seoul, South Korea | CDMO | Phase 2 | VIEW |
| 178. |  ENGEDI RX Roswell, Georgia, USA | CRO | Commercial | VIEW |
| 179. |  ETH Zürich Zurich, Switzerland | Biotech | Discovery | VIEW |
| 180. |  | CDMO | Commercial | VIEW |
| 181. |  EVERSANA Chicago, Illinois, USA | CRO | Commercial | VIEW |
| 182. |  EY Global Delivery Services (GDS) London, United Kingdom | CRO | Late Stage | VIEW |
| 183. |  Ecolab Inc. Saint Paul, USA | Pharma | Commercial | VIEW |
| 184. |  Eczacıbaşı Group Istanbul, Turkey | Pharma | Commercial | VIEW |
| 185. |  Elevance Health Indianapolis, USA | Digital Health | Commercial | VIEW |
| 186. |  Eli Lilly and Company Indianapolis, Indiana, USA | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 187. |  Emblem AI San Francisco, USA | Digital Health | Commercial | VIEW |
| 188. |  Emmes Group Rockville, Maryland, USA | CRO | N/A | VIEW |
| 189. |  Encompass Communications and Learning Edgewater, USA | CRO | - | VIEW |
| 190. |  | Biotech | Clinical | VIEW |
| 191. |  | Biotech | Preclinical | VIEW |
| 192. |  EpiDisease Valencia, Spain | Diagnostics | Commercial | VIEW |
| 193. |  Erasmus MC Rotterdam, Netherlands | Biotech | Discovery | VIEW |
| 194. |  Ergomed Guildford, United Kingdom | CRO | Commercial | VIEW |
| 195. |  Escientia Life Sciences Hyderabad, India | CDMO | Commercial | VIEW |
| 196. |  Escientia Life Sciences South Windsor, Connecticut, USA | CDMO | Commercial | VIEW |
| 197. |  | Pharma | Commercial | VIEW |
| 198. |  Esteve Healthcare Barcelona, Spain | Pharma | Commercial | VIEW |
| 199. |  Eurofins BioPharma Product Testing (BPT) Luxembourg City, Luxembourg | CRO | Commercial | VIEW |
| 200. |  European Medicines BV Lelystad, Netherlands | CRO | Commercial | VIEW |
| 201. |  Evernorth Health Services St. Louis, USA | Digital Health | Commercial | VIEW |
| 202. |  Evolution Health Group, LLC Pearl River, New York, USA | CRO | Commercial | VIEW |
| 203. |  Evox Therapeutics Oxford, United Kingdom | Biotech | Preclinical | VIEW |
| 204. |  Exeltis Florham Park, USA (Global HQ in Madrid, Spain) | Biotech | Commercial | VIEW |
| 205. |  | CDMO | Commercial | VIEW |
| 206. |  FELIQS Corporation Fukuoka, Japan | Biotech | Phase 1 | VIEW |
| 207. |  FFF Enterprises, Inc. Temecula, USA | CDMO | Commercial | VIEW |
| 208. |  | Pharma | Commercial | VIEW |
| 209. |  Fidelity Investments Boston, USA | Pharma | Commercial | VIEW |
| 210. |  | CDMO | Commercial | VIEW |
| 211. |  Fiocruz (Oswaldo Cruz Foundation) Rio de Janeiro, Brazil | Biotech | Commercial | VIEW |
| 212. |  Flagship Pioneering Cambridge, USA | Biotech | Discovery | VIEW |
| 213. |  Florence Healthcare Atlanta, USA | Digital Health | Commercial | VIEW |
| 214. |  Fondazione Don Carlo Gnocchi Milan, Italy | MedTech | Discovery | VIEW |
| 215. |  Forma Therapeutics Inc Watertown, USA | Biotech | Phase 3 | VIEW |
| 216. |  Fortrea Durham, North Carolina, USA | CRO | Commercial | VIEW |
| 217. |  Free Market Health Pittsburgh, USA | Digital Health | Series B | VIEW |
| 218. |  Freyr Solutions Princeton, New Jersey, USA | CRO | Commercial | VIEW |
| 219. |  Fujifilm Diosynth Biotechnologies Morrisville, North Carolina, USA | CDMO | Commercial | VIEW |
| 220. |  | Digital Health | Commercial | VIEW |
| 221. |  G&L Scientific Marlow, United Kingdom | CRO | Commercial | VIEW |
| 222. |  | Biotech | Phase 1|Phase 2|Commercial | VIEW |
| 223. |  GPW Group Saarbrücken, Germany | CRO | - | VIEW |
| 224. |  GemPharmatech Co., Ltd. Nanjing, China | CRO | Discovery | VIEW |
| 225. |  Genedata Basel, Switzerland | Digital Health | - | VIEW |
| 226. |  Genentech South San Francisco, California, United States | Biotech | Discovery through Commercial | VIEW |
| 227. |  | Digital Health | Commercial | VIEW |
| 228. |  Genorare B.V. Amsterdam, Netherlands | Digital Health | Discovery | VIEW |
| 229. |  George Mason University Fairfax, USA | Biotech | Phase 2 | VIEW |
| 230. |  Giddi Pharma Co., Ltd. Taichung City, Taiwan | CRO | Commercial | VIEW |
| 231. |  Giddi Pharma Co., Ltd. Taichung, Taiwan | CRO | Commercial | VIEW |
| 232. |  Global Life Sciences Alliance Philadelphia, PA, USA | CRO | Commercial | VIEW |
| 233. |  GlobalData Plc London, United Kingdom | Digital Health | Commercial | VIEW |
| 234. |  Guangzhou Cellprotek Pharmaceutical Guangzhou, China | Biotech | Phase 3 (Planning) | VIEW |
| 235. |  HBM Partners Zug, Switzerland | Biotech | Commercial | VIEW |
| 236. |  HEOR Cardiff, United Kingdom | CRO | - | VIEW |
| 237. |  HLB PEP Co., Ltd. Gwangju, South Korea | Biotech | Preclinical | VIEW |
| 238. |  Halozyme Therapeutics San Diego, USA | Biotech | Commercial | VIEW |
| 239. |  Hamad Bin Khalifa University (HBKU) Doha, Qatar | Biotech | Preclinical | VIEW |
| 240. |  Hanmi Pharmaceutical Co., Ltd. Seoul, South Korea | Biotech | Commercial | VIEW |
| 241. |  Harmony Biosciences Holdings, Inc. Plymouth Meeting, USA | Biotech | Commercial | VIEW |
| 242. |  Haymarket Media Group London, United Kingdom | Digital Health | Commercial | VIEW |
| 243. |  | Digital Health | Commercial | VIEW |
| 244. |  Heligenics Phoenix, Arizona, USA | Biotech | Discovery | VIEW |
| 245. |  Helix RA Mexico City, Mexico | CRO | Commercial | VIEW |
| 246. |  Hevolution Foundation Riyadh, Saudi Arabia | Biotech | Discovery | VIEW |
| 247. |  Holostem S.r.l. Modena, Italy | Biotech | Commercial | VIEW |
| 248. |  | Digital Health | Commercial | VIEW |
| 249. |  | MedTech | Commercial | VIEW |
| 250. |  Hong Kong University of Science and Technology (Guangzhou) Guangzhou, China | Biotech | Phase 2 | VIEW |
| 251. |  Hospital Israelita Albert Einstein São Paulo, Brazil | Diagnostics | Commercial | VIEW |
| 252. |  HungaroTrial CRO Budapest, Hungary | CRO | Commercial | VIEW |
| 253. |  Huron Consulting Group Chicago, USA | CRO | Commercial | VIEW |
| 254. |  Hyloris Pharmaceuticals SA Liège, Belgium | Biotech | Commercial | VIEW |
| 255. |  ICLOS-PDLC L'Hospitalet de Llobregat (Barcelona), Spain | CRO | N/A (Service Provider) | VIEW |
| 256. |  IQVIA Durham, North Carolina, United States (Primary) / Danbury, Connecticut, United States (Secondary) | CRO | N/A - Service Provider | VIEW |
| 257. |  IRCCS Ospedale San Raffaele Milan, Italy | Biotech | Discovery | VIEW |
| 258. |  IXICO plc London, United Kingdom | CRO | Commercial | VIEW |
| 259. |  Icarus Therapeutics San Diego, USA | Digital Health | N/A | VIEW |
| 260. |  Idorsia Allschwil, Switzerland | Biotech | Commercial | VIEW |
| 261. |  Illumina, Inc. San Diego, USA | Diagnostics | Commercial | VIEW |
| 262. |  Immorna Biotherapeutics Morrisville, USA | Biotech | Phase 2 | VIEW |
| 263. |  InClin, Inc. San Mateo, USA | CRO | N/A | VIEW |
| 264. |  Incyte Wilmington, Delaware, USA | Biotech | Commercial | VIEW |
| 265. |  Indegene Princeton, USA / Bangalore, India | CRO | N/A | VIEW |
| 266. |  Initial Therapeutics South San Francisco, USA | Biotech | Discovery | VIEW |
| 267. |  | CRO | Commercial | VIEW |
| 268. |  Insmed Incorporated Bridgewater, New Jersey, USA | Biotech | Commercial | VIEW |
| 269. |  Institute for Bioengineering of Catalonia (IBEC) Barcelona, Spain | Biotech | Preclinical | VIEW |
| 270. |  Institute for Medical Information Processing, Biometry and Epidemiology (IBE), LMU Munich Munich, Germany | CRO | Commercial | VIEW |
| 271. |  Institute of Health Economics (IHE) Edmonton, Canada | Digital Health | - | VIEW |
| 272. |  Instituto Politécnico Nacional (IPN) Mexico City, Mexico | Biotech | Discovery | VIEW |
| 273. |  Intellia Therapeutics Cambridge, USA | Biotech | Phase 3 | VIEW |
| 274. |  Intermountain Health Salt Lake City, USA | Pharma | - | VIEW |
| 275. |  Inttl Advocare New Delhi, India | CRO | Commercial | VIEW |
| 276. |  IntuitionLabs San Jose, California, USA | Digital Health | Commercial | VIEW |
| 277. |  Ionis Pharmaceuticals, Inc. Carlsbad, USA | Biotech | Commercial | VIEW |
| 278. |  Ipsen Boulogne-Billancourt, France | Pharma | Commercial | VIEW |
| 279. |  Ironwood Pharmaceuticals Boston, USA | Biotech | Commercial | VIEW |
| 280. |  Italfarmaco Group Milan, Italy | Pharma | Commercial | VIEW |
| 281. |  JCR Pharmaceuticals Co., Ltd. Ashiya, Japan | Biotech | Phase 3 | VIEW |
| 282. |  JW Pharmaceutical Gwacheon, South Korea | Pharma | Commercial | VIEW |
| 283. |  Jaba Recordati Porto Salvo, Portugal | Pharma | Commercial | VIEW |
| 284. |  Jazz Pharmaceuticals Dublin, Ireland | Pharma | Phase 1 through Commercial | VIEW |
| 285. |  Jubilant Biosys Limited Noida, India | CRO | Discovery | VIEW |
| 286. |  KMK Consulting Inc. Morristown, New Jersey, USA | CRO | Commercial | VIEW |
| 287. |  Kapadi Raleigh, North Carolina, USA | CRO | Commercial | VIEW |
| 288. |  Katrina Rogers Consulting LLC Spokane, Washington, USA | CRO | Commercial | VIEW |
| 289. |  Kedrion Biopharma Barga, Italy | Biotech | Commercial | VIEW |
| 290. |  Kindstar Global Wuhan, China | Diagnostics | Commercial | VIEW |
| 291. |  Kinexum Harpers Ferry, USA | CRO | Commercial | VIEW |
| 292. |  Kiniksa Pharmaceuticals London, United Kingdom | Biotech | Commercial | VIEW |
| 293. |  Klassen Consulting, LLC Livingston, TX, USA | CRO | - | VIEW |
| 294. |  Klick Health Toronto, Canada | Digital Health | - | VIEW |
| 295. |  Komtur Pharmaceuticals Freiburg, Germany | CRO | Commercial | VIEW |
| 296. |  Korro Bio, Inc. Cambridge, USA | Biotech | Phase 1/2 | VIEW |
| 297. |  KromaTiD, Inc. Longmont, USA | Biotech | Discovery | VIEW |
| 298. |  | Pharma | Commercial | VIEW |
| 299. |  Kyung Hee University Seoul, South Korea | Biotech | Phase 3 | VIEW |
| 300. |  Labcorp Burlington, North Carolina, USA | Diagnostics | Commercial | VIEW |
| 301. |  Laboratoires Servier Orléans, France | Pharma | Preclinical through Commercial | VIEW |
| 302. |  Laboratorios Bagó Buenos Aires, Argentina | Biotech | Commercial | VIEW |
| 303. |  Lekli Pharma (LEKLI sh.p.k.) Tirana, Albania | Biotech | Commercial | VIEW |
| 304. |  Leoben Research Rome, Italy | CRO | Commercial | VIEW |
| 305. |  Lexbridge Co., Ltd. Sakai, Osaka, Japan | CRO | Commercial | VIEW |
| 306. |  Life Science Strategy Group Menlo Park, USA | CRO | Commercial | VIEW |
| 307. |  LifeSci Communications New York, USA | CRO | - | VIEW |
| 308. |  Link Innovations Bengaluru, India | Digital Health | Commercial | VIEW |
| 309. |  | CDMO | Commercial | VIEW |
| 310. |  Lucid Group Buckinghamshire, United Kingdom | Digital Health | - | VIEW |
| 311. |  Lumanity Morristown, New Jersey, USA | CRO | - | VIEW |
| 312. |  MARS Group Inc. Bloomington, Illinois, USA | CRO | Commercial | VIEW |
| 313. |  MEPSGEN Seoul, South Korea | Biotech | Preclinical | VIEW |
| 314. |  MMS Holdings Inc. Canton, USA | CRO | Commercial | VIEW |
| 315. |  MRH Regulatory Sciences San Francisco, USA | CRO | Commercial | VIEW |
| 316. |  Macrogen Europe Amsterdam, Netherlands | CRO | Commercial | VIEW |
| 317. |  Macrogen Japan Corp. Kyoto, Japan | CRO | Discovery | VIEW |
| 318. |  Mahzi Therapeutics South San Francisco, USA | Biotech | Phase 1/2 | VIEW |
| 319. |  Marin Biologic Laboratories Novato, USA | CRO | Discovery | VIEW |
| 320. |  Mass General Brigham Boston, Massachusetts, USA | Biotech | Commercial | VIEW |
| 321. |  Medical University of Silesia Katowice, Poland | Diagnostics | Commercial | VIEW |
| 322. |  | CRO | Discovery | VIEW |
| 323. |  Medidata Solutions New York City, USA | Digital Health | - | VIEW |
| 324. |  Medison Pharma Petah Tikva, Israel | Biotech | Commercial | VIEW |
| 325. |  Meiji Seika Pharma Tokyo, Japan | Pharma | Phase 3 | VIEW |
| 326. |  Menarini Stemline New York, USA | Biotech | Commercial | VIEW |
| 327. |  Mentor Technical Group Caguas, Puerto Rico | CRO | Commercial | VIEW |
| 328. |  Merck & Co., Inc. Rahway, New Jersey, United States | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 329. |  Mersana Therapeutics Cambridge, USA | Biotech | Phase 1 | VIEW |
| 330. |  MetaQ Trials Tel Aviv, Israel | Digital Health | Commercial | VIEW |
| 331. |  Metagenomi Emeryville, USA | Biotech | Preclinical | VIEW |
| 332. |  Metagenomi Therapeutics, Inc. Emeryville, United States | Biotech | Preclinical | VIEW |
| 333. |  MetrioPharm AG Zurich, Switzerland | Biotech | Phase 2 | VIEW |
| 334. |  Metrum Research Group Tariffville, Connecticut, USA | CRO | - | VIEW |
| 335. |  | Biotech | Preclinical | VIEW |
| 336. |  Micron, Inc. Minato-ku, Tokyo, Japan (with Kobe operations history) | CRO | Clinical Development Support | VIEW |
| 337. |  Minaris Advanced Therapies Philadelphia, PA, USA | CDMO | Commercial | VIEW |
| 338. |  Minovia Therapeutics Tirat Carmel, Israel | Biotech | Phase 2 | VIEW |
| 339. |  | CRO | - | VIEW |
| 340. |  Mirum Pharmaceuticals Foster City, USA | Biotech | Commercial | VIEW |
| 341. |  | Biotech | Commercial | VIEW |
| 342. |  Mogam Institute for Biomedical Research Seoul, South Korea | Biotech | Discovery|Preclinical | VIEW |
| 343. |  Mubadala Bio Abu Dhabi, United Arab Emirates | CDMO | Commercial (Manufacturing & Distribution) | VIEW |
| 344. |  Mucpharm Kogarah, Sydney, New South Wales 2217, Australia | Biotech | Phase 2 | VIEW |
| 345. |  NJ Bio, Inc. Princeton, USA | CRO | Discovery | VIEW |
| 346. |  | Biotech | Commercial | VIEW |
| 347. |  | CRO | Commercial | VIEW |
| 348. |  NPDK Bioconsulting San Diego, California | CRO | Commercial | VIEW |
| 349. |  | CRO | Discovery | VIEW |
| 350. |  | Biotech | Preclinical | VIEW |
| 351. |  National Hospital Organization (NHO) Tokyo, Japan | MedTech | Discovery | VIEW |
| 352. |  National Resilience, Inc. La Jolla, California, USA | CDMO | Commercial | VIEW |
| 353. |  Neurocrine Biosciences San Diego, USA | Biotech | Commercial | VIEW |
| 354. |  Neurogene Inc. New York, NY | Biotech | Phase 2 | VIEW |
| 355. |  Neurophth Therapeutics Wuhan, China | Biotech | Phase 3 | VIEW |
| 356. |  New Zealand Clinical Research (NZCR) Auckland, New Zealand | CRO | Commercial | VIEW |
| 357. |  Nexcea Limited (formerly Glasshouse Health Limited) Manchester, United Kingdom | CRO | - | VIEW |
| 358. |  Nicklaus Children's Health System Miami, USA | MedTech | Commercial | VIEW |
| 359. |  Nobelpharma Co., Ltd. Tokyo, Japan | Biotech | Commercial | VIEW |
| 360. |  NouStarX Westport, CT, United States | Digital Health | - | VIEW |
| 361. |  Novartis Basel, Switzerland | Pharma | Phase 2, Phase 3, Commercial | VIEW |
| 362. |  Novo Nordisk Bagsværd, Denmark | Pharma | Commercial | VIEW |
| 363. |  | CRO | Discovery through Phase IV | VIEW |
| 364. |  Novumgen London, United Kingdom | Biotech | Discovery | VIEW |
| 365. |  Null Hypothesis Hangzhou, China | Digital Health | Commercial | VIEW |
| 366. |  Oceanus Plus Beijing, China | Digital Health | Commercial | VIEW |
| 367. |  On/Off Therapeutics Paris, France | Biotech | Preclinical | VIEW |
| 368. |  Onassis Cardiac Surgery Center Athens, Greece | MedTech | - | VIEW |
| 369. |  Oncogenexe Biotech Pty Ltd Fourways, South Africa | Biotech | Phase 2 | VIEW |
| 370. |  Oncotelic Therapeutics Agoura Hills, California, USA | Biotech | Phase 1|Phase 2|Phase 3 | VIEW |
| 371. |  Optum Eden Prairie, Minnesota, USA | Digital Health | Commercial | VIEW |
| 372. |  Oracle Corporation Austin, Texas, USA | Pharma | Commercial | VIEW |
| 373. |  Orchard Therapeutics London, United Kingdom | Biotech | Commercial | VIEW |
| 374. |  | Biotech | Commercial | VIEW |
| 375. |  Otsuka Pharmaceutical Chiyoda, Tokyo, Japan | Pharma | Phase 1 through Commercial | VIEW |
| 376. |  Otsuka Pharmaceutical Chiyoda, Tokyo, Japan | Pharma | Phase 1 through Commercial | VIEW |
| 377. |  PBS Regulatory Consulting Bridgewater, New Jersey, USA | CRO | Commercial | VIEW |
| 378. |  PPD (Pharmaceutical Product Development) Wilmington, North Carolina, USA | CRO | Commercial | VIEW |
| 379. |  | CRO | Commercial | VIEW |
| 380. |  Parexel Raleigh, North Carolina, USA | CRO | Phase I-IV (as a CRO, Parexel manages client pipelines, not its own) | VIEW |
| 381. |  Partex NV Eschborn, Germany | Biotech | Phase 2 | VIEW |
| 382. |  Peking Union Medical College Hospital (PUMCH) Beijing, China | Biotech | Discovery | VIEW |
| 383. |  Perceptive London, United Kingdom | CRO | Commercial | VIEW |
| 384. |  Petauri Nashville, Tennessee, USA | CRO | Private Equity Backed | VIEW |
| 385. |  Pfizer New York, United States | Pharma | Phase 1-3 and pending approval | VIEW |
| 386. |  | Digital Health | Private Equity-Backed | VIEW |
| 387. |  PharmaLex Mannheim, Germany (Hans-Thoma-Straße 22, 68163 Mannheim) / Bad Homburg, Germany | CRO | N/A - Service Provider (not drug developer) | VIEW |
| 388. |  PharmaLex (now Cencora PharmaLex) Multiple global headquarters; main offices in Switzerland and US | CRO | Consulting/Support across all stages - Discovery through Phase 4 | VIEW |
| 389. |  | CRO | N/A | VIEW |
| 390. |  Pharmosa Biopharm Inc. Taipei, Taiwan | Biotech | Phase 1 / Phase 3 (via partners) | VIEW |
| 391. |  Pharvaris N.V. Leiden, Netherlands / Zug, Switzerland | Biotech | Phase 3 | VIEW |
| 392. |  PicnicHealth San Francisco, USA | Digital Health | Commercial | VIEW |
| 393. |  Pierre Fabre Group Castres, France | Pharma | Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 394. |  Piramal Pharma Limited Mumbai, India | CDMO | Commercial Manufacturing (primarily services other companies' pipelines) | VIEW |
| 395. |  Policlinico Gemelli Rome, Italy | CRO | Commercial | VIEW |
| 396. |  Polygon Health Analytics LLC Chalfont, PA, United States | Digital Health | - | VIEW |
| 397. |  Precigen Germantown, Maryland, USA | Biotech | Commercial | VIEW |
| 398. |  Precision Medicine Group Bethesda, USA | CRO | Commercial | VIEW |
| 399. |  Precision Value & Health Gladstone, NJ, USA | CRO | - | VIEW |
| 400. |  Precision for Medicine Bethesda, Maryland, USA | CRO | Commercial | VIEW |
| 401. |  Premier Research Morrisville, North Carolina, USA | CRO | N/A (Service Provider) | VIEW |
| 402. |  Premium Pharmaser Tunis, Tunisia | CRO | Commercial | VIEW |
| 403. |  Prisma Biotech Corporation Taipei, Taiwan | Biotech | - | VIEW |
| 404. |  ProductLife Group Paris, France | CRO | Private Equity Backed | VIEW |
| 405. |  Promethean Drug Ideas Thane, India | Biotech | Discovery | VIEW |
| 406. |  | CRO | - | VIEW |
| 407. |  Pyramid Laboratories, Inc. Costa Mesa, USA | CDMO | Commercial | VIEW |
| 408. |  Qbic St-Denijs-Westrem, Belgium | Biotech | Discovery | VIEW |
| 409. |  Qilu Pharmaceutical 8888 Lvyou Road, High-tech Zone, Jinan, China | Pharma | Discovery through Commercial | VIEW |
| 410. |  REGENXBIO Inc. Rockville, USA | Biotech | Phase 3 | VIEW |
| 411. |  | Biotech | Discovery | VIEW |
| 412. |  RWS Group Chalfont St Peter, United Kingdom | CRO | Commercial | VIEW |
| 413. |  Rancho BioSciences San Diego, USA | CRO | - | VIEW |
| 414. |  Rani Therapeutics San Jose, USA | Biotech | Phase 1 | VIEW |
| 415. |  | CRO | Commercial | VIEW |
| 416. |  Recordati S.p.A. Milan, Italy | Pharma | Commercial | VIEW |
| 417. |  Recursion Pharmaceuticals Salt Lake City, Utah, USA | Biotech | Phase 1-2 | VIEW |
| 418. |  | CRO | - | VIEW |
| 419. |  | Diagnostics | Commercial | VIEW |
| 420. |  Rho Durham, North Carolina, USA | CRO | Commercial | VIEW |
| 421. |  Rhythm Pharmaceuticals, Inc. Boston, USA | Biotech | Commercial | VIEW |
| 422. |  | Biotech | Phase 2 | VIEW |
| 423. |  | CRO | Commercial | VIEW |
| 424. |  | Pharma | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 425. |  Roche Holding AG (via businesspartner.roche.com portal) Basel, Switzerland | Pharma | Phase 1 through Commercial | VIEW |
| 426. |  SAIFU Laboratories (Beijing Saifu Pharmaceutical Research Institute Co., Ltd.) Beijing, China | CRO | Discovery | VIEW |
| 427. |  SB Pharma Solutions, LLC Chicago, USA | CRO | - | VIEW |
| 428. |  SSI Strategy Parsippany, New Jersey, USA | CRO | - | VIEW |
| 429. |  ST Pharm Co., Ltd. Siheung, South Korea | CDMO | Phase 1 | VIEW |
| 430. |  Saama Technologies Campbell, USA | Digital Health | Commercial | VIEW |
| 431. |  Saatchi & Saatchi Health / Saatchi & Saatchi Wellness New York, USA / London, UK | Digital Health | - | VIEW |
| 432. |  Salience Learning New York, USA | CRO | - | VIEW |
| 433. |  | Biotech | Clinical | VIEW |
| 434. |  | Pharma | Preclinical through Phase 3 | VIEW |
| 435. |  Saol Therapeutics Roswell, USA | Biotech | Phase 3 | VIEW |
| 436. |  Sarepta Therapeutics Cambridge, USA | Biotech | Commercial | VIEW |
| 437. |  Sartorius Göttingen, Germany | CDMO | Commercial | VIEW |
| 438. |  Scantox Group Lille Skensved, Denmark | CRO | Discovery | VIEW |
| 439. |  Scenic Biotech Amsterdam, The Netherlands | Biotech | Preclinical to IND-enabling | VIEW |
| 440. |  Seattle Children's Seattle, USA | Biotech | Phase 1 | VIEW |
| 441. |  | Diagnostics | Commercial | VIEW |
| 442. |  Sensorion Montpellier, France | Biotech | Phase 1/2 | VIEW |
| 443. |  SeqOne Genomics Montpellier, France | Digital Health | Commercial | VIEW |
| 444. |  Shiga University of Medical Science Otsu, Japan | Biotech | Discovery | VIEW |
| 445. |  Shionogi & Co., Ltd. Osaka, Japan | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 446. |  Shionogi B.V. (Shionogi Europe) Amsterdam, Netherlands | Pharma | Commercial | VIEW |
| 447. |  Simtra BioPharma Solutions Bloomington, Indiana, USA | CDMO | Commercial | VIEW |
| 448. |  Sinedore Holdings Ltd. Taipei, Taiwan | Biotech | Discovery | VIEW |
| 449. |  Spot Biosystems Palo Alto, USA | Biotech | Preclinical | VIEW |
| 450. |  StemSynergy Therapeutics Miami, Florida, USA | Biotech | Preclinical and IND-enabling | VIEW |
| 451. |  Stoke Therapeutics Bedford, USA (Moving to Waltham, MA in late 2026) | Biotech | Phase 3 | VIEW |
| 452. |  Sumitomo Pharma America, Inc. Marlborough, USA | Pharma | Commercial | VIEW |
| 453. |  Svar Life Science Malmö, Sweden | Diagnostics | Commercial | VIEW |
| 454. |  Swati Spentose Private Limited Mumbai, India | CDMO | Commercial | VIEW |
| 455. |  Syncona Ltd St. Peter Port, Guernsey (Operational office in London, UK) | Biotech | Commercial | VIEW |
| 456. |  Syndax Pharmaceuticals Waltham, Massachusetts, USA | Biotech | Commercial | VIEW |
| 457. |  Syneos Health Morrisville, North Carolina, USA | CRO | Not applicable - Syneos Health supports client pipelines across all stages (Discovery to Commercial) | VIEW |
| 458. |  Syner-G BioPharma Group Framingham, Massachusetts, USA | CRO | Private Equity Backed | VIEW |
| 459. |  Synexa Life Sciences Leiden, Netherlands | CRO | Commercial | VIEW |
| 460. |  Syngene International Bengaluru, India | CRO | Commercial | VIEW |
| 461. |  TFS HealthScience Lund, Sweden | CRO | Commercial | VIEW |
| 462. |  Taho Pharmaceuticals Ltd. Taipei, Taiwan | Biotech | Phase 3 | VIEW |
| 463. |  Taipei Veterans General Hospital Taipei, Taiwan | MedTech | Discovery | VIEW |
| 464. |  Takeda Pharmaceutical Company Tokyo, Japan | Pharma | Phase 3 | VIEW |
| 465. |  Takeda Pharmaceutical Company Limited Tokyo, Japan | Pharma | Commercial | VIEW |
| 466. |  Tanabe Pharma Corporation Osaka, Japan | Pharma | Commercial | VIEW |
| 467. |  Tata Consultancy Services Mumbai, India | CRO | Commercial | VIEW |
| 468. |  Technology Resources, Inc. West Chester, Pennsylvania, USA | CRO | Commercial | VIEW |
| 469. |  Tempris GmbH Holzkirchen, Germany | MedTech | Commercial | VIEW |
| 470. |  TerSera Therapeutics Deerfield, IL, USA | Biotech | Commercial | VIEW |
| 471. |  The ConfluenceElite Group, LLC Greater Philadelphia Area, USA | CRO | Commercial | VIEW |
| 472. |  Thermo Fisher Scientific Waltham, Massachusetts, United States | CRO | Full spectrum - from drug discovery through Phase I-III and commercial | VIEW |
| 473. |  | CRO | Commercial | VIEW |
| 474. |  Tonix Pharmaceuticals Holding Corp. Chatham, New Jersey, USA | Biotech | Commercial | VIEW |
| 475. |  Travalcon Scarborough, Canada | Digital Health | Commercial | VIEW |
| 476. |  TrialBlaze Wilmington, North Carolina, USA | CRO | Commercial | VIEW |
| 477. |  Trinity Life Sciences Waltham, USA | CRO | Commercial | VIEW |
| 478. |  Trio Health Louisville, CO, USA | Digital Health | - | VIEW |
| 479. |  Tyra Biosciences, Inc. Carlsbad, USA | Biotech | Phase 2 | VIEW |
| 480. |  | Pharma | Commercial | VIEW |
| 481. |  UK Biobank Stockport, United Kingdom | Diagnostics | Commercial | VIEW |
| 482. |  Ultragenyx Pharmaceutical Inc. Novato, USA | Biotech | Commercial | VIEW |
| 483. |  Umbizo Ltd Manchester, United Kingdom | Digital Health | - | VIEW |
| 484. |  Unidade Local de Saúde de Coimbra, E.P.E. Coimbra, Portugal | Digital Health | - | VIEW |
| 485. |  Unidade Local de Saúde de São João (ULSSJ) Porto, Portugal | Digital Health | Discovery | VIEW |
| 486. |  Universidad Miguel Hernández de Elche (UMH) Elche, Spain | Biotech | Discovery | VIEW |
| 487. |  Universidad de San Martín de Porres (USMP) Lima, Peru | Biotech | Discovery | VIEW |
| 488. |  Universitair Ziekenhuis Antwerpen (UZA) Edegem, Belgium | Biotech | Commercial | VIEW |
| 489. |  University Medical Center Utrecht (UMC Utrecht) Utrecht, Netherlands | MedTech | Discovery | VIEW |
| 490. |  University of British Columbia Vancouver, Canada | Biotech | Discovery | VIEW |
| 491. |  University of California, Berkeley Berkeley, USA | Biotech | Discovery | VIEW |
| 492. |  University of Cincinnati Cincinnati, USA | Biotech | Commercial | VIEW |
| 493. |  University of Colorado Boulder Boulder, USA | Biotech | Discovery | VIEW |
| 494. |  University of Essex Colchester, United Kingdom | Biotech | Discovery | VIEW |
| 495. |  University of Wisconsin–Madison Madison, USA | Biotech | Commercial | VIEW |
| 496. |  Value & Access Advisors, LLC St. Petersburg, USA | CRO | - | VIEW |
| 497. |  Value Genome LLC Exton, Pennsylvania, USA | CRO | Commercial | VIEW |
| 498. |  Vault Bioventures San Diego, United States | CRO | - | VIEW |
| 499. |  | Digital Health | Private Equity | VIEW |